DAVID, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 2.708
AS - Asia 2.249
EU - Europa 1.648
SA - Sud America 302
AF - Africa 89
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.002
Nazione #
US - Stati Uniti d'America 2.645
SG - Singapore 966
CN - Cina 767
IE - Irlanda 361
SE - Svezia 250
BR - Brasile 244
FI - Finlandia 242
IT - Italia 229
HK - Hong Kong 198
DE - Germania 191
UA - Ucraina 165
VN - Vietnam 128
TR - Turchia 113
NL - Olanda 86
ZA - Sudafrica 73
CA - Canada 53
RU - Federazione Russa 41
GB - Regno Unito 35
AR - Argentina 22
BD - Bangladesh 15
EC - Ecuador 12
BE - Belgio 11
IN - India 11
IQ - Iraq 11
FR - Francia 9
UZ - Uzbekistan 8
ES - Italia 7
PL - Polonia 7
VE - Venezuela 7
CL - Cile 6
MX - Messico 5
PY - Paraguay 5
AT - Austria 4
JO - Giordania 4
PE - Perù 4
PK - Pakistan 4
TN - Tunisia 4
AU - Australia 3
CI - Costa d'Avorio 3
ID - Indonesia 3
JP - Giappone 3
KE - Kenya 3
MA - Marocco 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
EU - Europa 2
KZ - Kazakistan 2
LU - Lussemburgo 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
CG - Congo 1
CH - Svizzera 1
CO - Colombia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UY - Uruguay 1
Totale 7.002
Città #
Singapore 441
Dublin 360
Chandler 347
Santa Clara 322
Jacksonville 303
Ashburn 298
Beijing 200
Hong Kong 198
Izmir 106
San Mateo 92
Boardman 91
Nanjing 87
Dearborn 82
Princeton 77
Johannesburg 70
Ann Arbor 64
Ho Chi Minh City 53
Los Angeles 52
Wilmington 50
Toronto 44
Hebei 42
Shenyang 40
Parma 39
Dallas 37
Jinan 35
New York 33
Helsinki 32
Moscow 32
Shanghai 31
Columbus 23
Hanoi 23
Kunming 23
Nanchang 23
Tianjin 23
Buffalo 22
São Paulo 20
Changsha 19
Bologna 18
Bremen 16
Council Bluffs 15
Jiaxing 15
Munich 15
Woodbridge 15
Des Moines 13
Hefei 13
Seattle 13
Brussels 11
Guangzhou 11
Zhengzhou 11
Haikou 10
Haiphong 10
Genoa 9
Norwalk 9
Brooklyn 8
Nuremberg 8
Tashkent 8
Chengdu 7
Hangzhou 7
San Francisco 7
The Dalles 7
Turku 7
Warsaw 7
Brasília 6
Fuzhou 6
Goiânia 6
Houston 6
Stockholm 6
Taiyuan 6
Duncan 5
Napoli 5
Ningbo 5
Rio de Janeiro 5
Rockville 5
Rome 5
Auburn Hills 4
Baghdad 4
Belo Horizonte 4
Borås 4
Buenos Aires 4
Caxias do Sul 4
Da Nang 4
Denver 4
Falls Church 4
Guayaquil 4
Kocaeli 4
Lima 4
London 4
Montreal 4
Ninh Bình 4
Piacenza 4
Taizhou 4
Abidjan 3
Amman 3
Ananindeua 3
Aracaju 3
Atlanta 3
Boston 3
Botucatu 3
Campinas 3
Chennai 3
Totale 4.265
Nome #
IL PROGETTO PIRP (PREVENZIONE INSUFFICIENZA RENALE PROGRESSIVA) DELLA REGIONE EMILIA-ROMAGNA: ANALISI DEI RISULTATI PRELIMINARI 206
CALCIFICASSI ESITATA IN GUARIGIONE DOPO TERAPIA CON TIOSOLFATO 135
CLINICAL POLICIES ON THE MANAGEMENT OF CHRONIC KIDNEY DISEASE PATIENTS IN ITALY 126
Burnout in health care providers of dialysis service in Northern Italy—a multicentre study 124
IMPROVEMENT OF INTRADIALYTIC TOLERANCE WITH LOW VOLUME DIALYSIS AND BICARBONATE BUFFERING OF DIALYSATE. 122
Clinical heterogeneity of hereditary coproporphyria: diagnostic usefulness of biochemical studies. Study of a familial case 121
A SIMPLE APPROACH FOR ASSESSING EQUILIBRATED KT/VB2M ON A ROUTINE BASIS. 119
ADHERENCE OF HUMAN MONOCYTES TO HAEMODIALYSIS MEMBRANES 119
ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION INDUCES PROINFLAMMATORY ACTIVITY IN HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS. 117
CLINICAL EFFECTS OF ONLINE DIALYSATE AND INFUSION FLUIDS 116
2-h DIALYSIS: A REALISTIC GOAL ? 115
High-efficiency dialysis with PMMA dialyzers: treatment dose delivery and long-term results 112
Albumin loss in on-line haemodiafiltration 111
HEMOFILTRATION: PREDILUTION VERSUS POSTDILUTION 111
ALTERNATIVE PATHWAY ACTIVATION OF COMPLEMENT BY CULTURED HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS 109
BEHAVIOUR OF B2-MICROGLOBULIN REMOVAL WITH DIFFERENT DIALYSIS SCHEDULES 107
Bacterial contamination of the dialysis fluid in different dialyzing machines 106
BASIC THERAPEUTIC REQUIREMENTS IN THE TREATMENT OF SEPSIS IN ACUTE RENAL FAILURE 105
An overview of hemodialysis and oxidant stress 104
Severe acute valproic acid intoxication successfully treated with hemodiafiltration without hemoperfusion 104
A clinical stratification tool for chronic kidney disease progression rate based on classification tree analysis 101
ADEQUACY OF TREATMENT OF UREMIA IN THE NINETIES 101
STORIA E PRINCIPI BIOFISICI GENERALI DELLE TECNICHE CONVETTIVE 100
GLUCOSE METABOLISM AND LARGER MOLECULE REMOVAL IN LONG-TERM HIGH-EFFICIENCY HEMOFILTRATION 100
Tolerance to ultrafiltration in hemodialysis 95
CYCLOSPORIN A AND DRUG INTERACTION. 95
Sarcoid granulomatous nephritis with isolated and reversible renal failure. A case report. 94
THE SIGNIFICANCE OF THE HBeAG/ANTI HBe SYSTEM IN HEMODIALYSISPATIENTS. A MULTICENTER STUDY. 94
Aliskiren Combined with Losartan in Type 2 Diabetesand Nephropathy 94
HEMOFILTRATION AND HEMODIAFILTRATION REDUCEINTRADIALYTIC HYPOTENSION IN ESRD 93
Identification of operational clues to dry weight prescription in hemodialysis using bioimpedance vector analysis 93
ASSOCIAZIONE TRA LIVELLI DI ACIDO URICO E RISCHIO DI PROGRESSIONE DELL’INSUFFICIENZA RENALE O DI MORTE PER OGNI CAUSA 93
Organic contamination in dialysis water: trichloroethylene as a model compound. 92
Variable radiological lung nodule evaluation leads to divergent management recommendations 91
PRESENTAZIONE DI UNA FORMULA PER IL CALCOLO IMMEDIATO DEL KT/V DELLA BETA2 MICROGLOBULINA 91
L'emodialisi e la dialisi peritoneale 90
REVERSIBLE ACUTE CYCLOSPORINE NEPHROTOXICITY INDUCED BY COLCHICINE ADMINISTRATION 89
Hemodiafiltration and high-flux hemodialysis with polyethersulfone membranes 88
ROLE OF PLATELET ACTIVATING FACTOR IN HEMODIALYSIS. 88
DANGER OF UNNECESSARILY PROLONGED DIALYSIS SESSION: CARPAL TUNNEL SYNDROME 87
Alterations of the cytokine network in hemodialysis 87
Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change 86
CORRECTION OF UREMIC ACIDOSIS BY HEMODIALYSIS 86
PRE-POSTDILUTION HEMOFILTRATION 85
Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC). 85
EFFECTS OF ADD-ON FLUVASTATIN THERAPY IN PATIENTS WITH CHRONIC PROTEINURIC NEPHROPATHY ON DUAL RENIN-ANGIOTENSIN SYSTEM BLOCKADE: THE ESPLANADE TRIAL 84
Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial. 82
IL REBOUND E IL KT/V EQUILIBRATO DELLA BETA2 MICROGLOBULINA NELLE DIFFERENTI TECNICHE AD ALTO FLUSSO. 82
Long-term outcome and clinical significance of orthostatic proteinuria. 82
Urea in Exhaled Breath Condensate of Uraemics and Patients with Chronic Airway Diseases 82
Preventing the epidemic of cardiovascular disease: new perspectives in extracorporeal substitutive treatment 81
THE EMILIA-ROMAGNA REGION PIRP PROGRAMME ( PREVENTION IN PROGRESSION OF PROGRESSIVE RENAL INSUFFICIENCY) 79
TERAPIA CON CALCIFEDIOLO NEI PAZIENTI CON CKD E DEFICIT DI VITAMINA D. 79
EFFETTI DELLA TERAPIA PROLUNGATA CON CALCITRIOLO SU FGF23 E SUL METABOLISMO CALCIO-FOSFORICO NELL’IRC. 78
Dialysis strategies 77
Disinfection in dialysis, using aldehydes. Theoretical considerations and practical use 75
Urinary soluble CD14 mediates human proximal tubular epithelial cell injury induced by LPS 75
Phosphate levels in patients treated with low-flux haemodialysis, pre-dilution haemofiltration and haemodiafiltration: post hoc analysis of a multicentre, randomized and controlled trial 75
Immunological aspects of urinary tract infections 74
Contribution of echotomography (ET) to transcutaneous renal needle-biopsy (RNB) and to the detection of possible complications 73
THE HEMATOPOIETIC SYSTEM IN RENAL FAILURE 73
IRON-REPLETE HAEMODIALYSIS PATIENTS DO NOT REQUIRE HIGHER ERYTHROPOIETIN DOSAGES WHEN CONVERTING FROM SUBCUTANEOUS TO INTRAVENOUS ADMINISTRATION. RESULTS OF THE ITALIAN STUDY ON ERYTHROPOIETIN CONVERTING (ISEC). 73
TANDEM PLASMA-EXCHANGE (PE) DIALYSIS. UNA VARIANTE SEMPLIFICATA. 72
RISULTATI DELL’ECOCARDIOGRAFIA ESOFAGEA E TRANSTORACICA IN PAZIENTI IN EMODIALISI SENZA CARDIOPATIE CLINICAMENTE RILEVANTI 71
Determination of urinary albumin excretion in subclinical forms of glomerulonephritis by electroimmunodiffusion. 71
COMPARISON OF 3 AUTOMATED ASSAYS FOR C-REACTIVE PROTEIN IN END-STAGE RENAL DISEASE: CLINICAL AND EPIDEMIOLOGICAL IMPLICATIONS 71
THE COST/BENEFIT RATIO OF RENAL REPLACEMENT THERAPY 69
EFFETTI A MEDIO TERMINE DEL CALCITRIOLO NEI PAZIENTI CON INSUFFICIENZA RENALE CRONICA E IPERPARATIROIDISMO LIEVE-MODERATO 69
PRODUCTION OF PLATELET ACTIVATING FACTOR BY HUMAN NEUTROPHILS AFTER BACKFILTRATION OF ENDOTOXIN CONTAMINATED DIALYSATE. 69
Renal insufficiency (RI) evolving to a definitive cure in sarcoidosic granulomatous nephritis (SGN) 69
THE ROLE OF PLATELET-ACTIVATING FACTOR IN THE BIOCOMPATIBILITY OF HEMODIALYSIS MEMBRANES 66
HEMOFILTRATION-INDUCED SERUM MODIFICATIONS IN THE PATTERN OF LARGER MOLECULES 66
QUANTIFICAZIONE DELL’EFFICIENZA DIALITICA PER L’UREA E PER LA BETA2 MICROGLOBULINA NELLE DIFFERENTI TECNICHE AD ALTO FLUSSO. 65
PREDILUTION HEMOFILTRATION. CLINICAL EXPERIENCE AND REMOVAL OF SMALL MOLECULAR WEIGHT SOLUTES 64
THE ROLE OF ADSORPTION IN 2-MICROGLOBULIN REMOVAL 60
IN VITRO AND IN VIVO BIOCOMPATIBILITY OF SUBSTITUTED CELLULOSE AND SYNTHETIC MEMBRANES 60
SARCOID GRANULOMATOUS NEPHRITIS WITH ISOLATED AND REVERSIBLE RENAL FAILURE. A CASE REPORT. 58
Totale 7.011
Categoria #
all - tutte 24.414
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.414


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021238 0 0 0 0 0 1 24 1 119 7 83 3
2021/2022359 2 1 9 6 10 7 51 62 19 47 39 106
2022/20231.243 143 110 78 82 109 151 5 75 441 3 28 18
2023/2024326 29 56 12 9 37 67 0 29 9 15 25 38
2024/20251.607 33 89 95 43 194 286 7 65 217 153 125 300
2025/20261.477 272 246 309 164 463 23 0 0 0 0 0 0
Totale 7.011